Georgia just took the biggest step forward for medical cannabis patients in more than a decade. On Tuesday May 12th, Governor Brian Kemp signed Senate Bill 220, the Putting Georgia’s Patients First Act, officially expanding our state’s medical cannabis program and joining 40 other states with a comprehensive medical program.
For the more than 34,000 Georgians already registered in the program, and the thousands more who will now qualify, this is the moment we’ve been working toward for years. At Botanical Sciences, we testified in support of SB220, and we’re proud to be a Georgia-grown, Georgia-based provider helping make this expansion a reality for our patients.
Here’s exactly what changed, what it means for you, and how to get started.
The Quick Summary: What SB220 Actually Does
SB220 passed with strong bipartisan support. The Senate voted 39-17, and the House passed it 144-21 before it was sent to the Governor’s desk. The final, enrolled version of the bill makes five major changes Georgia patients have been asking for:
- Replaces the 5% THC cap with a 12,000 mg total THC possession limit
- Legalizes vaporization as a delivery method for patients 21 and older
- Adds lupus as a qualifying condition
- Removes “severe or end-stage” requirements for conditions like cancer, Parkinson’s, and multiple sclerosis
- Officially renames “low THC oil” to “medical cannabis” in Georgia law
Let’s break down what each of these actually means for patients.
1. Real Medicine, Real Potency: The 5% Cap Is Gone
For years, Georgia’s medical cannabis program was one of the most restrictive in the country because of a 5% THC cap that left many patients without effective relief. Tinctures, capsules, and oils simply weren’t strong enough for patients dealing with serious chronic pain, severe nausea, or treatment-resistant conditions.
SB220 replaces the percentage cap with a possession limit of 12,000 milligrams of total THC at any one time. This shift mirrors how every other comprehensive medical cannabis state regulates the program, by total dosage rather than artificially limited potency.
To put 12,000 mg in perspective: most medical cannabis patients use somewhere between 10 mg and 40 mg of THC per day, depending on their condition and tolerance. That means a 12,000 mg possession cap is enough to comfortably cover several months of treatment for the typical patient, giving Georgians the flexibility to fill prescriptions on a normal schedule without running up against the limit.
The result: physicians can now recommend products that actually match the clinical needs of the patient in front of them.
2. Vaporization Is Now Legal for Patients 21+
One of the biggest patient complaints about Georgia’s old program was the wait. Oils and tinctures can take 30 to 90 minutes to provide relief, far too slow for someone in a pain crisis, an MS flare, or active chemotherapy nausea.
SB220 legalizes vaporization for registered patients 21 and over, including vape products and cannabis flower used for vaporization at home. This is a major win for patients who need fast-acting relief, and it brings Georgia in line with the standard of care offered in most medical cannabis states.
A few important details:
- Smoking remains prohibited. Only vaporization is permitted.
- Patients under 21 cannot use vaporization. Oils, tinctures, capsules, and other approved forms remain available.
- Public use is still restricted. The law preserves protections for workplaces, schools, and public spaces.
3. Lupus Added as a Qualifying Condition
If you have lupus and have been told you don’t qualify under Georgia’s old list, that just changed.
SB220 adds lupus (systemic lupus erythematosus) to Georgia’s list of qualifying conditions. This addition reflects years of patient testimony and clinical research showing that cannabis can help manage the inflammation, chronic pain, and fatigue that come with living with lupus.
For lupus patients, this means access to a new option for managing symptoms inside Georgia’s regulated medical program, without leaving the state or relying on unregulated products.
4. The “Severe or End-Stage” Barrier Is Gone
This change is quieter than the THC cap headline, but for many families it may be the most meaningful one.
Under the old law, patients with conditions like cancer, Parkinson’s disease, and multiple sclerosis had to be classified as “severe” or “end-stage” before they could qualify for medical cannabis. That meant patients had to wait until they were at their sickest to get help that could have improved their quality of life much earlier.
SB220 removes that requirement. A diagnosis is now enough. Patients no longer have to be in the worst phase of their illness to receive a recommendation.
5. “Medical Cannabis,” Not “Low THC Oil”
This may sound like just a name change, but it actually matters. Georgia’s program has been technically invisible to many federal agencies and even some patients because the law called it “low THC oil” rather than recognizing it as medicine.
By formally renaming it “medical cannabis” throughout Georgia’s code, SB220 brings our state’s terminology in line with the other 40 states with comprehensive programs, and signals that Georgia now treats this as a legitimate medical program.
What This Means If You’re Already a Patient
If you’re already registered with the Georgia Access to Medical Cannabis Commission, your card is still valid. As implementation rolls out:
- New product types (vaporizers, flower for vaporization) will become available at licensed dispensaries
- Higher-potency products will be available based on your physician’s recommendation
- Renewal procedures have been streamlined under the new law
Stop into any Botanical Sciences dispensary and our team will walk you through what’s new and help you find products that match your treatment plan.
What This Means If You’re Not Yet Registered
If you’ve held off because of Georgia’s old restrictions, or because you didn’t qualify before, now is the time to look again.
You may now qualify if you have one of the following conditions in Georgia under SB220: intractable pain, PTSD (patients 18+), cancer, seizure disorders (related to epilepsy or trauma-related head injuries), multiple sclerosis, Parkinson’s disease, Crohn’s disease, autism spectrum disorder (adults, or minors with severe autism), Alzheimer’s disease, sickle cell disease, Tourette’s syndrome, AIDS, peripheral neuropathy, mitochondrial disease, ALS (amyotrophic lateral sclerosis), hospice care patients, epidermolysis bullosa, hemorrhagic stroke recovery, and lupus (newly added under SB220). Under the new law, cancer, Parkinson’s, MS, ALS, Alzheimer’s, AIDS, and peripheral neuropathy patients no longer have to be classified as “severe” or “end-stage” to qualify.
The process is straightforward:
- Get a physician certification from a Georgia-licensed doctor
- Register with the Georgia Access to Medical Cannabis Commission to get your medical cannabis card
- Visit a licensed dispensary like Botanical Sciences to access your medicine
👉 Start your medical cannabis card application here
Why Botanical Sciences
Botanical Sciences is one of Georgia’s licensed medical cannabis producers, growing cannabis in Georgia and operating dispensaries across the state. Our CEO, Gary Long, was on record supporting SB220 throughout the legislative process, telling reporters that the bill moves Georgia from a low-THC oil-based program to a true medical cannabis program, the same kind of program available in 40 other states.
We are a Georgia company serving Georgia patients. Every product we sell is grown, processed, tested, and dispensed in compliance with Georgia law, and now, under SB220, we’ll be able to offer the broader range of products that Georgia patients have been asking for.
Stay Up to Date as SB220 Rolls Out
Implementation will take time. Some changes, like vaporization product availability, will roll out as the Georgia Access to Medical Cannabis Commission updates regulations and as licensed producers like us bring new products to market. We’ll be sending out updates the moment new products are available and as new rules are finalized.
📬 Subscribe to our newsletter to be the first to know when:
- New SB220-authorized products hit our dispensary shelves
- Vaporization products become available
- The Commission releases new patient guidance
- New educational resources for patients and caregivers go live
The Bottom Line
SB220 is the most significant expansion of Georgia’s medical cannabis program since it was created in 2015. It removes barriers that kept patients from accessing real relief, expands eligibility to Georgians living with lupus, and finally treats medical cannabis as the medicine it is.
If you’re a Georgia patient, or you love someone who could benefit, this law was written for you.
Ready to get started?
This post is for educational purposes and does not constitute medical or legal advice. Consult a Georgia-licensed physician to determine whether medical cannabis is right for your condition. Medical cannabis is available only to patients registered with the Georgia Access to Medical Cannabis Commission.
